BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report)’s stock price shot up 0.8% on Tuesday . The stock traded as high as $7.97 and last traded at $7.97. 761 shares were traded during trading, a decline of 73% from the average session volume of 2,861 shares. The stock had previously closed at $7.90.
BioSyent Stock Up 0.8 %
The company has a 50 day moving average price of $7.63 and a 200-day moving average price of $7.81.
BioSyent Increases Dividend
The firm also recently declared a dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, March 3rd were issued a dividend of $0.0347 per share. This represents a dividend yield of 1.77%. The ex-dividend date was Friday, February 28th. This is a positive change from BioSyent’s previous dividend of $0.03.
BioSyent Company Profile
BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.
Read More
- Five stocks we like better than BioSyent
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Mid-Cap Medical Stocks Outperforming the Market
- How to Short Nasdaq: An Easy-to-Follow Guide
- The Top-Ranked Insider Buys From April by Market Cap
- Industrial Products Stocks Investing
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.